Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 128
- Companies
Another Canadian cannabis producer pauses production over ‘edibles’ dispute with Health Canada
INDIVA LIMITED Another Canadian cannabis producer pauses production over ‘edibles’ dispute with Health Canada Indiva Limited has halted production of some of its products due to a disagreement with Health Canada over the classification of its cannabis lozenges, reports MJBiz.
- Press releases
MGC Pharmaceuticals Has Completed The Pre-Clinical Study On CimetrA™, Exploring The Mechanism Of Action (MoA) Of The Product
PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing and sale of breakthrough cannabis-based medicines, announces that its current Home Office licence has been successfully updated to allow the commercial sale of its high Δ9-tetrahydrocannabinol (“THC”) product, following the Company’s…
- Medical
Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow
TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to announce major changes to the country’s medical cannabis framework.
- Uncategorized
Vorgeschlagene Änderungen des deutschen Rahmens für medizinisches Cannabis würden “ernsthafte Auswirkungen auf Patienten und Industrie” haben, wenn sie morgen in Kraft treten
Es wird erwartet, dass der Gemeinsame Bundesausschuss (G-BA) morgen wichtige Änderungen an den Rahmenbedingungen für medizinisches Cannabis in Deutschland bekannt geben wird.
- Hemp Industry
Synthetic cannabinoids further rift between cannabis and hemp industries
Synthetic cannabinoids further rift between cannabis and hemp industries The rise of intoxicating, hemp-derived cannabinoids has widened a rift in the cannabis industry, MJ Biz Daily reports.
- Data & Analysis
Will Twitter’s ‘Relaxation’ On Cannabis Advertising Help Break The Industry’s Social Media Ad Embargo?
TWITTER has become the first major social media platform to openly allow the advertisement of cannabis brands.
- Markets & Stocks
Kentucky House passes bill to regulate Delta-8 THC products
DELTA-8 THC Kentucky House passes bill to regulate Delta-8 THC products A bill to regulate Delta-8 THC sped through the House of Representatives on Thursday, writes Liam Niemeyer of the Kentucky Lantern for Marijuana Moment.
- Companies
Kanabo Launches New Online Medical Cannabis Clinic ‘Treat It’, Offering Access To Doctors In ‘Less Than 24 Hours’
KANABO Group has today announced the launch of a new online medical cannabis clinic for pain management, Treat It.
- Companies
Cannabis companies are having trouble winning over institutional investors
CANNABIS INVESTORS Cannabis companies are having trouble winning over institutional investors Writing for Bloomberg, Peyton Forte explores the cannabis industry’s ongoing difficulties in winning over institutional investors – an issue that will be coming up more frequently as the market grows and more states legalize cannabis use.
- Markets & Stocks
European Cannabis Stocks Review: Akanda Implement’s 1-10 Stock Consolidation, IMC Slashes 20% Of Staff, & More From DanCann Pharma
Akanda Akanda has become the latest NASDAQ-listed cannabis company to enact a stock consolidation in order to avoid delisting from the stock exchange.
- Adult-Use
SXSW: Which political party will legalize weed nationally?
CANNABIS PROHIBITION SXSW: Which political party will legalize weed nationally?
- Companies
Ananda Developments Takes ‘Big Step’ Towards Revenues And Potential NHS Funding With £2m MRX Global Acquisition
ANANDA Developments has today announced the acquisition of MRX Global in a deal set to transform the company’s offering.











